| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000267280.1 |
Ponatinib |
Brain lower grade glioma |
0.023970439 |
Resistant |
| ENSG00000267280.1 |
Ponatinib |
Skin cutaneous melanoma |
0.019719601 |
Resistant |
| ENSG00000267280.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.030024082 |
Sensitive |
| ENSG00000267280.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.011663447 |
Sensitive |
